Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream

Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream

Bibliographic Details
Main Authors: Shannon Nugent, BS, Alexandra J. Coromilas, MD, Joseph C. English, III, MD, Misha Rosenbach, MD
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:JAAD Case Reports
Subjects:
granulomatous disorders
JAK inhibitor
Janus kinase
necrobiosis lipoidica
ruxolitinib
tofacitinib
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512622003848
Description
ISSN:2352-5126

Similar Items